ANAPTYSBIO INC (ANAB) Stock Income Statement
NASDAQ:ANAB - US0327241065 - Common Stock
20.14 USD
+0.01 (+0.05%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 123.16M | 91.28M | 17.16M | 10.29M | 63.18M | |||
| Operating Expenses | 209.30M | 206.23M | 174.23M | 125.44M | 119.99M | |||
| Research and Development | 163.81M | 163.84M | 132.28M | 88.80M | 98.50M | |||
| Selling, General, and Administrative Expenses | 45.49M | 42.39M | 41.95M | 36.64M | 21.49M | |||
| Operating Income | -86.14M | -114.95M | -157.07M | -115.15M | -56.81M | |||
| Interest Income/Expense | 18.65M | 19.79M | 18.87M | 7.55M | 430.00K | |||
| Other Income/Expense | -65.03M | -50.07M | -18.09M | -21.10M | -1.41M | |||
| Non Recurring Items | N/A | 0.00 | -7.34M | N/A | N/A | |||
| Income Before Taxes | -132.52M | -145.23M | -163.62M | -128.70M | -57.80M | |||
| Income Tax | 77.00K | 3.00K | -4.00K | 20.00K | 0.00 | |||
| Net Income | -132.59M | -145.23M | -163.62M | -128.72M | -57.80M | |||
| EBITDA | -85.56M | -114.34M | -156.42M | -114.47M | -56.19M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.48 | -5.12 | -6.08 | -4.57 | -2.11 | |||
| Non GAAP EPS | -4.48 | -5.21 | -6.08 | -4.57 | -2.05 | |||
| Statistics | ||||||||
| Profit Margin | -107.66% | -159.10% | -953.66% | -1250.92% | -91.48% | |||
| Operating Profit Margin | -69.94% | -125.93% | -915.50% | -1119.05% | -89.92% | |||
All data in USD